ES2234797T3 - Procedimiento para la preparacion de citalopram partiendo de 5-formilftalida. - Google Patents

Procedimiento para la preparacion de citalopram partiendo de 5-formilftalida.

Info

Publication number
ES2234797T3
ES2234797T3 ES01830517T ES01830517T ES2234797T3 ES 2234797 T3 ES2234797 T3 ES 2234797T3 ES 01830517 T ES01830517 T ES 01830517T ES 01830517 T ES01830517 T ES 01830517T ES 2234797 T3 ES2234797 T3 ES 2234797T3
Authority
ES
Spain
Prior art keywords
formula
procedure
group
citalopram
triphenylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01830517T
Other languages
English (en)
Spanish (es)
Inventor
Leone Dall'asta
Giovanni Cotticelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Infosint SA
Original Assignee
Infosint SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infosint SA filed Critical Infosint SA
Application granted granted Critical
Publication of ES2234797T3 publication Critical patent/ES2234797T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES01830517T 2001-08-02 2001-08-02 Procedimiento para la preparacion de citalopram partiendo de 5-formilftalida. Expired - Lifetime ES2234797T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01830517A EP1281707B1 (en) 2001-08-02 2001-08-02 Process for the preparation of 5-subtituted isobenzofurans

Publications (1)

Publication Number Publication Date
ES2234797T3 true ES2234797T3 (es) 2005-07-01

Family

ID=8184643

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01830517T Expired - Lifetime ES2234797T3 (es) 2001-08-02 2001-08-02 Procedimiento para la preparacion de citalopram partiendo de 5-formilftalida.

Country Status (23)

Country Link
US (1) US7166729B2 (xx)
EP (1) EP1281707B1 (xx)
JP (1) JP2005501056A (xx)
KR (1) KR20040043176A (xx)
CN (1) CN1298713C (xx)
AR (1) AR036212A1 (xx)
AT (1) ATE286037T1 (xx)
AU (1) AU2002325385B2 (xx)
BG (1) BG108554A (xx)
BR (1) BR0211858A (xx)
CA (1) CA2456004A1 (xx)
DE (1) DE60108105T2 (xx)
DK (1) DK1281707T3 (xx)
ES (1) ES2234797T3 (xx)
HK (1) HK1070357A1 (xx)
HU (1) HUP0401166A3 (xx)
MX (1) MXPA04001030A (xx)
PL (1) PL368320A1 (xx)
PT (1) PT1281707E (xx)
RO (1) RO122147B1 (xx)
TW (1) TWI225055B (xx)
WO (1) WO2003011846A2 (xx)
ZA (1) ZA200400841B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
AU2003263155A1 (en) * 2002-09-20 2004-04-08 H. Lundbeck A/S Method for manufacture of dihydroisobenzofuran derivatives
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
CA2932121A1 (en) 2007-11-30 2009-06-11 Newlink Genetics Corporation Ido inhibitors
CN106632182A (zh) * 2016-12-07 2017-05-10 万全万特制药（厦门）有限公司 草酸艾司西酞普兰脱甲基杂质的制备方法
DE112019006382T8 (de) * 2018-12-22 2021-12-09 Malladi Drugs And Pharmaceuticals Ltd. NEUES VERFAHREN ZUR HERSTELLUNG VONR-PHENYLACETYLCARBINOL UND β-AMINOALKOHOLEN

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
NZ501737A (en) * 1997-07-08 2001-10-26 H Method for the preparation of citalopram using Grignard reagent 4-halogen-fluorophenyl and 3-halogen-N,N-dimethyl-propylamine
CZ296537B6 (cs) * 1999-04-14 2006-04-12 H. Lundbeck A/S Zpusob výroby citalopramu a meziprodukty
ITMI991486A1 (it) * 1999-07-06 2001-01-06 Vis Farmaceutici S P A Processo per la sintesi di citalopram
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
IT1319686B1 (it) * 2000-12-12 2003-10-23 C D Farmasint S R L Procedimento di preparazione di citalopram.

Also Published As

Publication number Publication date
AU2002325385B8 (en) 2003-02-17
PT1281707E (pt) 2005-04-29
HK1070357A1 (en) 2005-06-17
KR20040043176A (ko) 2004-05-22
EP1281707B1 (en) 2004-12-29
US20040230065A1 (en) 2004-11-18
AR036212A1 (es) 2004-08-18
DE60108105T2 (de) 2005-12-08
TWI225055B (en) 2004-12-11
PL368320A1 (en) 2005-03-21
WO2003011846A3 (en) 2003-11-27
AU2002325385B2 (en) 2007-07-05
DE60108105D1 (de) 2005-02-03
BG108554A (bg) 2005-03-31
WO2003011846B1 (en) 2003-12-24
US7166729B2 (en) 2007-01-23
BR0211858A (pt) 2004-09-21
CA2456004A1 (en) 2003-02-13
DK1281707T3 (da) 2005-05-02
ATE286037T1 (de) 2005-01-15
WO2003011846A2 (en) 2003-02-13
MXPA04001030A (es) 2004-12-03
EP1281707A1 (en) 2003-02-05
CN1298713C (zh) 2007-02-07
ZA200400841B (en) 2005-02-02
CN1555370A (zh) 2004-12-15
JP2005501056A (ja) 2005-01-13
HUP0401166A2 (hu) 2004-09-28
RO122147B1 (ro) 2009-01-30
HUP0401166A3 (en) 2007-05-29

Similar Documents

Publication Publication Date Title
BG64823B1 (bg) Метод за получаването на циталопрам
US20140081035A1 (en) Process for preparation of dronedarone by mesylation
BRPI0610336A2 (pt) processo para preparação de 5-(4-[4-(5-ciano-3-indolil)butil]-1-piperazinil)benzofura n-2-carboxamida
ES2234797T3 (es) Procedimiento para la preparacion de citalopram partiendo de 5-formilftalida.
ES2284506T3 (es) Metodo de producir tiametoxam.
KR920002295B1 (ko) 프롤리디논 유도체의 제조방법
ES2592154T3 (es) Derivado de N-hidroxiformamida y medicamento que contiene el mismo
US20070060759A1 (en) Method for the preparation of citalopram
JP4908706B2 (ja) ベンゾフラン誘導体
AU2002325385A1 (en) Process for the preparation of 5-substituted isobenzofurans
US7148364B2 (en) Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile
ES2223766T3 (es) Procedimientoparala preparacion 5-formilfthaluro.
AU2022245255A1 (en) New process for the synthesis of 5-{5-chloro-2-[(3s)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1h)-carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-carboxylic acid derivatives and its application for the production of pharmaceutical compounds
JP2001502298A (ja) 方法および新規中間体
JP2008546765A (ja) （アルコキシカルボニルアミノ）−アルキルスルホネートの製造方法
AU2002325386A1 (en) Process for the preparation of 5-formylphthalide
MXPA06004568A (en) Method for the preparation of citalopram